比较一线双支架取栓器与单支架取栓器技术的随机研究:TWIN2WIN
这项多中心随机对照盲法评定主要结局研究纳入108例发病24小时内大血管闭塞卒中患者,随机分配接受一线单支架取栓器或双支架取栓器技术。双支架组首次再通率46%高于单支架组24%(调整比值比2.72,95%CI 1.19-6.46),症状性颅内出血两组无显著差异。
要点
- 双支架取栓器一线技术首次再通率46%,高于单支架取栓器的24%(调整比值比2.72)
- 3次尝试内显著再灌注率两组分别为单支架84%和双支架89%,差异未达统计学显著
- 症状性颅内出血发生率单支架6%、双支架10%,差异未达统计学显著
核心结论
- 在接受取栓的卒中患者中,一线双支架取栓器技术安全,且在实现首次再通方面优于单支架取栓器,但在最终再通方面未显示优效。
- 对临床结局的影响应在专门设计的试验中研究。
研究设计与样本
- 多中心、随机、对照、盲法评定主要结局研究。
- 纳入发病24小时内大血管闭塞卒中并接受取栓的患者,初始血管造影确认大血管闭塞后随机分配至一线单支架取栓器组或双支架取栓器组。
- 如需进一步取栓,研究者可选择其偏好的技术;首次再通和最终成功再通由盲法研究者集中评定。
- 数据安全监查委员会在预设中期分析后因达到预设疗效界值而停止入组。
- 2022年4月至2023年10月共纳入108例患者,单支架取栓器组50例(46%),双支架取栓器组58例(54%)。
主要发现
- 首次再通:单支架取栓器组50例中12例(24%)vs 双支架取栓器组58例中27例(46%),调整比值比2.72(95%CI 1.19-6.46)。
- 3次尝试内显著再灌注:单支架取栓器组42例(84%)vs 双支架取栓器组52例(89%),调整比值比1.74(95%CI 0.5-5.76),未达统计学显著。
- 平均取栓次数:单支架取栓器组2±1.3次 vs 双支架取栓器组1.7±1次,平均差-0.37(95%CI -0.9至0.06)。
- 症状性颅内出血:单支架取栓器组3例(6%)vs 双支架取栓器组6例(10%),调整比值比1.66(95%CI 0.40-8.35),未达统计学显著。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The double-stent retriever (SR) technique has been described as an effective rescue technique when single-SR fails to induce recanalization. We aimed to assess the safety and efficacy of first-line double-SR in patients with stroke undergoing thrombectomy. METHODS: This was a multicenter, randomized, controlled, blinded adjudicated primary outcome study. Patients with a large vessel occlusion stroke within 24 hours after onset and undergoing thrombectomy were included. Upon confirmation of large vessel occlusion on initial angiogram, patients were randomly allocated to receive a first-line strategy: single-SR versus double-SR technique. Investigators could use their technique of choice if further passes were needed. The primary objective was to evaluate the efficacy of double-SR defined as first-pass complete recanalization (expanded Treatment in Cerebral Infarction grade 2c-3) compared with single-SR. First-pass recanalization and final successful recanalization (expanded Treatment in Cerebral Infarction grade 2b50-3) were centrally assessed by a blinded investigator. The safety outcome was the occurrence of a symptomatic intracerebral hemorrhage. The data safety monitoring board stopped the recruitment after a preplanned interim analysis because a predefined efficacy boundary was reached. RESULTS: From April 2022 to October 2023, 108 patients were included: 50 (46%) in the single-SR group and 58 (54%) in the double-SR group. First-pass recanalization was achieved in 12 of 50 patients (24%) allocated to single-SR and 27 of 58 patients (46%) allocated to double-SR (adjusted odds ratio, 2.72 [95% CI, 1.19-6.46]). Substantial reperfusion within 3 attempts was obtained in 42 patients (84%) allocated to single-SR and in 52 patients (89%) allocated to double-SR (adjusted odds ratio, 1.74 [95% CI, 0.5-5.76]). The mean number of passes was 2±1.3 with single-SR and 1.7±1 with double-SR (mean difference, -0.37 [95% CI, -0.9 to 0.06]). A symptomatic intracerebral hemorrhage occurred in 3 patients (6%) allocated to single-SR and in 6 patients (10%) allocated to double-SR (adjusted odds ratio, 1.66 [95% CI, 0.40-8.35]). CONCLUSIONS: In patients with stroke undergoing thrombectomy, first-line double-SR is safe and superior to single-SR in achieving first-pass recanalization but not final recanalization. Implications on clinical outcomes should be studied in specifically designed trials. REGISTRATION: URL: https://www.clinicaltrials.gov; Unique identifier: NCT05632458.
引用
- Tomasello A, Moreu M, Terceño M, et al. Randomized Study Comparing First-Line Dual Versus Single-Stent Retriever Technique: TWIN2WIN. Stroke. 2024. PMID: 39704055. doi:10.1161/STROKEAHA.124.048496
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。